Skip to content
10-Q

Quarterly Report

AARDVARK THERAPEUTICS, INC. AARD

0001193125-25-280260

← back to feed
Filed
Nov 13, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 3, 2025 21.77M sh
Shares Diluted Q3 2025 · Sep 30, 2025 21.71M sh
Shares Diluted Q3 2025 · Sep 30, 2025 18.9M sh
Shares Diluted Q3 2025 · Sep 30, 2024 3.99M sh
Shares Diluted Q3 2025 · Sep 30, 2024 3.97M sh
Capex Q3 2025 · Sep 30, 2025 $95K
Capex Q3 2025 · Sep 30, 2024 $103K
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$37.36M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$10.36M
Short Term Investments Q3 2025 · Sep 30, 2025 $87.07M
Short Term Investments Q3 2025 · Dec 31, 2024 $12.02M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $39.29M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $61.64M
Stockholders Equity Q3 2025 · Sep 30, 2025 $122.38M
Stockholders Equity Q3 2025 · Jun 30, 2025 $136.93M
Stockholders Equity Q3 2025 · Dec 31, 2024 −$54.64M
Stockholders Equity Q3 2025 · Sep 30, 2024 −$46.17M
Stockholders Equity Q3 2025 · Jun 30, 2024 −$42.31M
Stockholders Equity Q3 2025 · Dec 31, 2023 −$34.8M
Current Liabilities Q3 2025 · Sep 30, 2025 $10.74M
Current Liabilities Q3 2025 · Dec 31, 2024 $4.93M
Total Liabilities Q3 2025 · Sep 30, 2025 $10.85M
Total Liabilities Q3 2025 · Dec 31, 2024 $5.39M
Current Assets Q3 2025 · Sep 30, 2025 $129.21M
Current Assets Q3 2025 · Dec 31, 2024 $74.14M
Total Assets Q3 2025 · Sep 30, 2025 $133.23M
Total Assets Q3 2025 · Dec 31, 2024 $77.51M
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.75
Eps Diluted Q3 2025 · Sep 30, 2025 −$2.12
Eps Diluted Q3 2025 · Sep 30, 2024 −$1.05
Eps Diluted Q3 2025 · Sep 30, 2024 −$2.97
Eps Basic Q3 2025 · Sep 30, 2025 −$0.75
Eps Basic Q3 2025 · Sep 30, 2025 −$2.12
Eps Basic Q3 2025 · Sep 30, 2024 −$1.05
Eps Basic Q3 2025 · Sep 30, 2024 −$2.97
Sga Expense Q3 2025 · Sep 30, 2025 $3.97M
Sga Expense Q3 2025 · Sep 30, 2025 $9.38M
Sga Expense Q3 2025 · Sep 30, 2024 $1.03M
Sga Expense Q3 2025 · Sep 30, 2024 $3.92M
Rd Expense Q3 2025 · Sep 30, 2025 $13.74M
Rd Expense Q3 2025 · Sep 30, 2025 $34.64M
Rd Expense Q3 2025 · Sep 30, 2024 $4.07M
Rd Expense Q3 2025 · Sep 30, 2024 $9.3M
Net Income Q3 2025 · Sep 30, 2025 −$16.32M
Net Income Q3 2025 · Sep 30, 2025 −$39.99M
Net Income Q3 2025 · Sep 30, 2024 −$4.18M
Net Income Q3 2025 · Sep 30, 2024 −$11.81M
Operating Income Q3 2025 · Sep 30, 2025 −$17.7M
Operating Income Q3 2025 · Sep 30, 2025 −$44.02M
Operating Income Q3 2025 · Sep 30, 2024 −$5.09M
Operating Income Q3 2025 · Sep 30, 2024 −$13.34M
Revenue Q3 2025 · Sep 30, 2025 $0